Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Disease × Vindesine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Leukemia 8 Lymphoma 7 Lymphoma, Large B-Cell, Diffuse 6 Neuroblastoma 5 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Neoplasm, Residual 2 Lymphoma, Large-Cell, Anaplastic 2 Burkitt Lymphoma 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancoast Syndrome 1 Neoplasm Metastasis 1 Melanoma 1 Mediastinal Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Leukemia, Biphenotypic, Acute 1 Hodgkin Disease 1 Disease 1 Adenocarcinoma of Lung 1

Interventions

Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Cyclophosphamide 6 Blood Specimen Collection 6 Prednisone 5 Positron Emission Tomography Computed Tomography 4 Mammography 4 Lenalidomide 4 Colonoscopy 4 pembrolizumab 3 Tomography, X-Ray Computed 3 Surveys and Questionnaires 3 Melphalan 3 Biopsy 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 weifuchun 2 obinutuzumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Magnetic Resonance Imaging 2 Injections 2 Gemcitabine 2 Exercise 2 Educational Status 2 Doxorubicin 2 Cytarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡